Displaying 1 - 10 of 32
September 16, 2026
Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale
Read MoreAugust 11, 2026
Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
Read MoreAugust 3, 2026
Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference
Read MoreAugust 3, 2026
Seer to Report Second Quarter 2026 Financial Results on August 11, 2026
Read MoreJuly 30, 2026
Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
Read MoreJuly 28, 2026
Seer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting
Read MoreJuly 20, 2026
Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY
Read MoreJuly 20, 2026
Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
Read MoreJuly 14, 2026
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
Read MoreJuly 8, 2026
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
Read More
Pagination